凭什么？国产智慧实验室公司融资3年拿4轮

Core Insights - The article highlights the recent A+ round financing of Suzhou Zhongxi Biological Information Co., Ltd. (Zhongxi Bio), which raised several million yuan, primarily aimed at enhancing its AI models and algorithms, as well as upgrading its automation workstation and instrument product lines [2][3]. Group 1: Financing and Growth - Zhongxi Bio has successfully completed four rounds of financing since 2023, with the latest round occurring just six months after the previous one in July 2025, indicating strong capital recognition and validation of its "smart laboratory" ecosystem strategy [3]. - The continuous success in financing is attributed to Zhongxi Bio's unique strategic positioning and clear commercialization path, focusing on a development model that integrates AI, automation equipment, and fully autonomous manufacturing [6]. Group 2: Strategic Transformation - Zhongxi Bio is transitioning from a single equipment supplier to a "smart laboratory" ecosystem builder, collaborating with industry leaders to create replicable "smart laboratory units," which enhances the integration of technology with specific scenarios [6]. - The founder of Zhongxi Bio, Zhu Bin, emphasizes that true intelligence goes beyond merely replacing human labor; it involves deep AI empowerment to reshape research and improve product quality and stability, enabling high-quality scaling [6]. Group 3: Innovation and Technology - The core innovation of Zhongxi Bio's "smart laboratory" system lies in constructing a closed-loop of "AI agents + automated experimental platforms," providing comprehensive intelligent support for research from hypothesis generation to experimental optimization [6]. - This system aims to establish a "data-driven - autonomous decision-making - cyclical evolution" framework, allowing laboratories to continuously self-optimize [6].